Skip to main content
. 2023 Aug 18;18(8):e0290239. doi: 10.1371/journal.pone.0290239

Table 2. Meta-analysis results of association between TNF-α-308G/A polymorphism and OSA.

Contrast model Subjects (cases/controls) Studies,n OR (95%CI) P * I2(%)
Total studies
allele model A vs. G 5190/5158 14 1.87 (1.47, 2.38) 0 69.10
dominant model AA/AG vs. GG 2595/2579 14 1.88(1.48, 2.39) 0 59.50
recessive model AA vs. AG/GG 2269/2360 11 2.83 (2.00, 4.00) 0 15.00
homozygous model AA vs. GG 2269/2360 11 3.30 (2.32, 4.68) 0 20.80
heterozygous model AG vs. GG 2595/2579 14 1.67 (1.36, 2.06) 0 38.80
Subgroup analysis
Caucasians
allele model A vs. G 1220/1958 5 1.40(1.03, 1.90) 0.033 53.50
dominant model AA/AG vs. GG 610/979 5 1.48 (1.03, 2.13) 0.035 56.30
recessive model AA vs. AG/GG 439/860 3 1.77 (1.00, 3.13) 0.048 0.00
homozygous model AA vs. GG 439/860 3 2.19 (1.23, 3.90) 0.008 0.00
heterozygous model AG vs. GG 610/979 5 1.46 (1.04, 2.06) 0.029 48.10
Asians
allele model A vs. G 3970/3200 9 2.30 (1.62, 3.26) 0 72.60
dominant model AA/AG vs. GG 1985/1600 9 2.23 (1.59, 3.14) 0 62.80
recessive model AA vs. AG/GG 1830/1500 8 3.51 (2.06, 5.98) 0 11.00
homozygous model AA vs. GG 1830/1500 8 4.22 (2.32, 7.67) 0 23.10
heterozygous model AG vs. GG 1985/1600 9 1.86 (1.40, 2.47) 0 39.60
Subgroup analysis
HB
allele model A vs. G 3798/3084 9 2.37 (1.68, 3.32) 0 70.40
dominant model AA/AG vs. GG 1899/1542 9 2.30 (1.66, 3.20) 0 58.70
recessive model AA vs. AG/GG 1830/1500 8 3.51 (2.06, 5.98) 0 11.00
homozygous model AA vs. GG 1830/1500 8 4.22 (2.32, 7.67) 0 23.10
heterozygous model AG vs. GG 1899/1542 9 1.89 (1.45, 2.47) 0 31.40
PB
allele model A vs. G 1392/2074 5 1.35 (0.98, 1.85) 0.068 58.40
dominant model AA/AG vs. GG 696/1037 5 1.41 (0.97, 2.06) 0.074 61.40
recessive model AA vs. AG/GG 439/860 3 1.77 (1.00, 3.13) 0.048 0.00
homozygous model AA vs. GG 439/860 3 2.19 (1.23, 3.90) 0.008 0.00
heterozygous model AG vs. GG 696/1037 5 1.40 (0.98, 2.00) 0.066 54.50

Abbreviation

HB: hospital-based

PB: population-based

Note:P*:P value for pooled OR.